These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1663094)

  • 1. Stabilization of [99mTc]HMPAO--1. Ethanolic preparation.
    Billinghurst MW; Abrams DN; Lawson MS
    Int J Rad Appl Instrum A; 1991; 42(7):607-12. PubMed ID: 1663094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.
    Pijarowska-Kruszyna J; Karczmarczyk U; Jaroń AW; Laszuk E; Radzik M; Garnuszek P; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2017; 20(2):88-94. PubMed ID: 28555448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilisation of high-activity 99mTc-d,l-HMPAO preparations with cobalt chloride and their biological behaviour.
    Mang'era KO; Vanbilloen HP; Schiepers CW; Verbruggen AM
    Eur J Nucl Med; 1995 Oct; 22(10):1163-72. PubMed ID: 8542901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc-HMPAO as a tracer of cerebral blood flow in newborn infants.
    Børch K; Greisen G
    J Cereb Blood Flow Metab; 1997 Apr; 17(4):448-54. PubMed ID: 9143227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects.
    Léveillé J; Demonceau G; Walovitch RC
    J Nucl Med; 1992 Apr; 33(4):480-4. PubMed ID: 1552328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of metabolic alterations on the accumulation of technetium-99m-labeled d,l-HMPAO in slices of rat cerebral cortex.
    Ahn CS; Tow DE; Yu CC; Greene RW
    J Cereb Blood Flow Metab; 1994 Mar; 14(2):324-31. PubMed ID: 8113327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of antioxidative ability in brain: technetium-99m-meso-HMPAO as an imaging agent for glutathione localization.
    Sasaki T; Toyama H; Oda K; Ogihara-Umeda I; Nishigori H; Senda M
    J Nucl Med; 1996 Oct; 37(10):1698-701. PubMed ID: 8862315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative 123I IMP and 99mTc HMPAO imaging in the dog following cocaine administration.
    Susskind H; Weber DA; Ivanovic M; Wong CT; DeHaan CE; Gavin PR
    Nucl Med Biol; 1996 Apr; 23(3):343-52. PubMed ID: 8782246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of technetium-99m-d,1-HMPAO to radiolysis in aqueous solutions.
    Tubergen K; Corlija M; Volkert WA; Holmes RA
    J Nucl Med; 1991 Jan; 32(1):111-5. PubMed ID: 1988613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual stimulation increases technetium-99m-HMPAO distribution in human visual cortex.
    Woods SW; Hegeman IM; Zubal IG; Krystal JH; Koster K; Smith EO; Heninger GR; Hoffer PB
    J Nucl Med; 1991 Feb; 32(2):210-5. PubMed ID: 1992020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The assessment of 99mTc-HMPAO tumor scintigraphy using VX-2 tumors in rabbits].
    Suga K; Uchisako H; Honma Y; Kuramitsu T; Itoh K; Nakagi K; Tanaka N; Ariyoshi I; Nakanishi T; Utsumi H
    Kaku Igaku; 1991 Sep; 28(9):1049-56. PubMed ID: 1770657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte labeling with 99mTc-HMPAO. The role of the in vitro stability of HMPAO on the labeling efficacy and image quality.
    Papós M; Láng J; Rajtár M; Csernay L
    Nucl Med Biol; 1994 Aug; 21(6):893-5. PubMed ID: 9234340
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased 99mTc-HMPAO uptake in ischemic stroke.
    Baird AE; Donnan GA
    Stroke; 1993 Aug; 24(8):1261-2. PubMed ID: 8342204
    [No Abstract]   [Full Text] [Related]  

  • 14. The behavior of 99mTc-hexamethylpropyleneamineoxime (99mTc-HMPAO) in blood and brain.
    Nakamura K; Tukatani Y; Kubo A; Hashimoto S; Terayama Y; Amano T; Goto F
    Eur J Nucl Med; 1989; 15(2):100-7. PubMed ID: 2920737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of technetium-99m-HMPAO and xenon-133 measurements of regional cerebral blood flow by SPECT.
    Payne JK; Trivedi MH; Devous MD
    J Nucl Med; 1996 Oct; 37(10):1735-40. PubMed ID: 8862321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 99mTc-D,L-hexamethylene-propyleneamine oxime (99mTc-HMPAO): basic kinetic studies of a tracer of cerebral blood flow.
    Andersen AR
    Cerebrovasc Brain Metab Rev; 1989; 1(4):288-318. PubMed ID: 2701656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Difference in the distribution of 123I-IMP and 99mTc-HMPAO in the striatum--comparison with 15O-PET].
    Otsuka M; Ichiya Y; Kuwabara Y; Sasaki M; Akashi Y; Yoshida T; Fukumura T; Masuda K
    Kaku Igaku; 1993 Apr; 30(4):389-95. PubMed ID: 8315889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procedure for red blood cell labelling with 99mTc-HMPAO. Methodology and quality control.
    Bassa P; García Garzón JR; Piera C; Pavía A; Minoves M; Moragas M; Pavía J; Lomeña F; Setoain J
    Nucl Med Biol; 1994 Oct; 21(7):963-7. PubMed ID: 9234351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
    van Dyck CH; Lin CH; Smith EO; Wisniewski G; Cellar J; Robinson R; Narayan M; Bennett A; Delaney RC; Bronen RA; Hoffer PB
    J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method for stabilising technetium-99m exametazime prepared from a commercial kit.
    Weisner PS; Bower GR; Dollimore LA; Forster AM; Higley B; Storey AE
    Eur J Nucl Med; 1993 Aug; 20(8):661-6. PubMed ID: 8404951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.